F Oldhafer1, K I Ringe2, K Timrott1, M Kleine1, O Beetz1, W Ramackers1, S Cammann1, J Klempnauer1, F W R Vondran3, H Bektas1,4. 1. ReMediES, Department of General, Visceral and Transplant Surgery, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany. 2. Department of Diagnostic and Interventional Radiology, Hannover Medical School, 30625, Hannover, Germany. 3. ReMediES, Department of General, Visceral and Transplant Surgery, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany. Vondran.Florian@MH-Hannover.de. 4. General, Visceral and Oncologic Surgery, Klinikum Bremen-Mitte/Bremen-Ost, Bremen, Germany.
Abstract
PURPOSE: Treatment of malignancies invading the hepatic veins/inferior vena cava is a surgical challenge. An ante situm technique allows luxation of the liver in front of the situs to perform tumor resection. Usually, cold perfusion and veno-venous bypass are applied. Our experience with modified ante situm resection relying only on total vascular occlusion is reported. METHODS: Retrospective analysis on an almost 15-year experience with ante situm resection without application of cold perfusion or veno-venous bypass RESULTS: The ante situm technique was applied on eight patients. Five individuals were treated due to intrahepatic cholangiocellular cancer and one case each for mixed cholangio-/hepatocellular carcinoma, colorectal liver metastasis, and pheochromocytoma. Trisectorectomy (n = 4), left hemihepatectomy, right hepatectomy, atypical resection, or mesohepatectomy (each n = 1) were performed, combined with dissection of suprahepatic/retrohepatic vena cava/hepatic veins. Venous reconstruction was achieved by reimplantation of hepatic veins with/without vascular replacement using allogeneic donor veins or PTFE grafts. Median total vascular occlusion of the liver was 23 min. Severe morbidity occurred in three patients (Dindo-Clavien > 3A). R0 status was achieved in six cases with a median overall survival of 33.5 months. CONCLUSIONS: Ante situm liver resection can be applied without cold perfusion nor veno-venous bypass with acceptable morbidity and mortality. However, this procedure remains challenging even for the experienced hepato-pancreato-biliary surgeon.
PURPOSE: Treatment of malignancies invading the hepatic veins/inferior vena cava is a surgical challenge. An ante situm technique allows luxation of the liver in front of the situs to perform tumor resection. Usually, cold perfusion and veno-venous bypass are applied. Our experience with modified ante situm resection relying only on total vascular occlusion is reported. METHODS: Retrospective analysis on an almost 15-year experience with ante situm resection without application of cold perfusion or veno-venous bypass RESULTS: The ante situm technique was applied on eight patients. Five individuals were treated due to intrahepatic cholangiocellular cancer and one case each for mixed cholangio-/hepatocellular carcinoma, colorectal liver metastasis, and pheochromocytoma. Trisectorectomy (n = 4), left hemihepatectomy, right hepatectomy, atypical resection, or mesohepatectomy (each n = 1) were performed, combined with dissection of suprahepatic/retrohepatic vena cava/hepatic veins. Venous reconstruction was achieved by reimplantation of hepatic veins with/without vascular replacement using allogeneic donor veins or PTFE grafts. Median total vascular occlusion of the liver was 23 min. Severe morbidity occurred in three patients (Dindo-Clavien > 3A). R0 status was achieved in six cases with a median overall survival of 33.5 months. CONCLUSIONS: Ante situm liver resection can be applied without cold perfusion nor veno-venous bypass with acceptable morbidity and mortality. However, this procedure remains challenging even for the experienced hepato-pancreato-biliary surgeon.
Entities:
Keywords:
Ante situm resection; Intrahepatic cholangiocellular cancer; Liver resection; Total vascular occlusion
Authors: Katrin Hoffmann; Markus A Weigand; Norbert Hillebrand; Markus W Büchler; Jan Schmidt; Peter Schemmer Journal: Clin Transplant Date: 2009 Jan-Feb Impact factor: 2.863
Authors: Ari Mehrabi; Hamid Fonouni; Mohammad Golriz; Stefan Hofer; Mohammad Hafezi; Nuh N Rahbari; Jürgen Weitz; Markus W Büchler; Jan Schmidt Journal: Dig Surg Date: 2011-04-29 Impact factor: 2.588
Authors: R Pichlmayr; A Weimann; K J Oldhafer; H J Schlitt; J Klempnauer; A Bornscheuer; A Chavan; E Schmoll; H Lang; G Tusch Journal: World J Surg Date: 1995 Nov-Dec Impact factor: 3.352
Authors: Mohammad H Fard-Aghaie; Alexandros Kantas; Georgios Makridis; Tim Reese; Kim C Wagner; Karl J Oldhafer Journal: Langenbecks Arch Surg Date: 2019-06-10 Impact factor: 3.445
Authors: F Oldhafer; K I Ringe; K Timrott; M Kleine; O Beetz; W Ramackers; S Cammann; J Klempnauer; H Bektas; Florian W R Vondran Journal: Langenbecks Arch Surg Date: 2019-06-29 Impact factor: 3.445